Crystal structure of the MuSK tyrosine kinase: Insights into receptor autoregulation

Structure

Volumn 10, Issue 9, 2002, Pages 1187-1196

  Till, Jeffrey H ^a   Becerra, Manuel ^a   Watty, Anke ^a   Lu, Yun ^a   Ma, Yuliang ^a   Neubert, Thomas A ^a   Burden, Steven J ^a   Hubbard, Stevan R ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crystal structure; Mass spectrometry; Neuromuscular junction; Phosphorylation; Signal transduction; Tyrosine kinase

Indexed keywords

ADENOSINE TRIPHOSPHATE; MUSCLE ENZYME; PROTEIN TYROSINE KINASE; CHOLINERGIC RECEPTOR; MUSK PROTEIN, HUMAN; MUSK PROTEIN, RAT;

ARTICLE; AUTOPHOSPHORYLATION; AUTOREGULATION; CATALYSIS; CRYSTAL STRUCTURE; CYTOPLASM; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME BINDING; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; STEADY STATE; ANIMAL; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; ELECTRICITY; KINETICS; MASS SPECTROMETRY; METABOLISM; PHOSPHORYLATION; PROTEIN CONFORMATION; RAT; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

ANIMALS; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; ELECTROSTATICS; KINETICS; MASS SPECTROMETRY; MODELS, MOLECULAR; PHOSPHORYLATION; PROTEIN CONFORMATION; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036710123     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(02)00814-6     Document Type: Article

References (46)

1. Jennings C.G., Dyer S.M., Burden S.J. Muscle-specific trk-related receptor with a kringle domain defines a distinct class of receptor tyrosine kinases. Proc. Natl. Acad. Sci. USA. 90:1993;2895-2899.
2. Valenzuela D.M., Stitt T.N., DiStefano P.S., Rojas E., Mattsson K., Compton D.L., Nunez L., Park J.S., Stark J.L., Gies D.R.et al. Receptor tyrosine kinase specific for the skeletal muscle lineage. expression in embryonic muscle, at the neuromuscular junction, and after injury Neuron. 15:1995;573-584.
3. DeChiara T.M., Bowen D.C., Valenzuela D.M., Simmons M.V., Poueymirou W.T., Thomas S., Kinetz E., Compton D.L., Rojas E., Park J.S.et al. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell. 85:1996;501-512.
4. McMahan U.J. The agrin hypothesis. Cold Spring Harb. Symp. Quant. Biol. 55:1990;407-418.
5. Glass D.J., Bowen D.C., Stitt T.N., Radziejewski C., Bruno J., Ryan T.E., Gies D.R., Shah S., Mattsson K., Burden S.J.et al. Agrin acts via a MuSK receptor complex. Cell. 85:1996;513-523.
6. Hopf C., Hoch W. Dimerization of the muscle-specific kinase induces tyrosine phosphorylation of acetylcholine receptors and their aggregation on the surface of myotubes. J. Biol. Chem. 273:1998;6467-6473.
7. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 103:2000;211-225.
8. Hubbard S.R., Till J.H. Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69:2000;373-398.
9. Pawson T., Nash P. Protein-protein interactions define specificity in signal transduction. Genes Dev. 14:2000;1027-1047.
10. Johnson L.N., Noble M.E., Owen D.J. Active and inactive protein kinases. structural basis for regulation Cell. 85:1996;149-158.
11. Hubbard S.R., Wei L., Ellis L., Hendrickson W.A. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature. 372:1994;746-754.
12. Mohammadi M., Schlessinger J., Hubbard S.R. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell. 86:1996;577-587.
13. Wybenga-Groot L.E., Baskin B., Ong S.H., Tong J., Pawson T., Sicheri F. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell. 106:2001;745-757.
14. Herbst R., Burden S.J. The juxtamembrane region of MuSK has a critical role in agrin-mediated signaling. EMBO J. 19:2000;67-77.
15. Wei L., Hubbard S.R., Hendrickson W.A., Ellis L. Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain. J. Biol. Chem. 270:1995;8122-8130.
16. Favelyukis S., Till J.H., Hubbard S.R., Miller W.T. Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Nat. Struct. Biol. 8:2001;1058-1063.
17. Watty A., Neubauer G., Dreger M., Zimmer M., Wilm M., Burden S.J. The in vitro and in vivo phosphotyrosine map of activated MuSK. Proc. Natl. Acad. Sci. USA. 97:2000;4585-4590.
18. Lu P.J., Zhou X.Z., Shen M., Lu K.P. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science. 283:1999;1325-1328.
19. Strochlic L., Cartaud A., Labas V., Hoch W., Rossier J., Cartaud J. MAGI-1c. a synaptic maguk interacting with musk at the vertebrate neuromuscular junction J. Cell Biol. 153:2001;1127-1132.
20. Zhou H., Glass D.J., Yancopoulos G.D., Sanes J.R. Distinct domains of MuSK mediate its abilities to induce and to associate with postsynaptic specializations. J. Cell Biol. 146:1999;1133-1146.
21. Till J.H., Ablooglu A.J., Frankel M., Bishop S.M., Kohanski R.A., Hubbard S.R. Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase. insights into kinase mechanism J. Biol. Chem. 276:2001;10049-10055.
22. Taylor S.S., Radzio-Andzelm E. Three protein kinase structures define a common motif. Structure. 2:1994;345-355.
23. Hubbard S.R. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16:1997;5572-5581.
24. Ablooglu A.J., Kohanski R.A. Activation of the insulin receptor's kinase domain changes the rate-determining step of substrate phosphorylation. Biochemistry. 40:2001;504-513.
25. Frankel M., Bishop S.M., Ablooglu A.J., Han Y.P., Kohanski R.A. Conformational changes in the activation loop of the insulin receptor's kinase domain. Protein Sci. 8:1999;2158-2165.
26. Shewchuk L.M., Hassell A.M., Ellis B., Holmes W.D., Davis R., Horne E.L., Kadwell S.H., McKee D.D., Moore J.T. Structure of the Tie2 RTK domain. self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail Struct. Fold. Des. 8:2000;1105-1113.
27. Ablooglu A.J., Frankel M., Rusinova E., Ross J.B., Kohanski R.A. Multiple activation loop conformations and their regulatory properties in the insulin receptor's kinase domain. J. Biol. Chem. 276:2001;46933-46940.
28. Yamaguchi H., Hendrickson W.A. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature. 384:1996;484-489.
29. White M.F., Livingston J.N., Backer J.M., Lauris V., Dull T.J., Ullrich A., Kahn C.R. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell. 54:1988;641-649.
30. Binns K.L., Taylor P.P., Sicheri F., Pawson T., Holland S.J. Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors. Mol. Cell. Biol. 20:2000;4791-4805.
31. Wang T., Li B.Y., Danielson P.D., Shah P.C., Rockwell S., Lechleider R.J., Martin J., Manganaro T., Donahoe P.K. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell. 86:1996;435-444.
32. Huse M., Chen Y.G., Massague J., Kuriyan J. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell. 96:1999;425-436.
33. Jones G., Moore C., Hashemolhosseini S., Brenner H.R. Constitutively active MuSK is clustered in the absence of agrin and induces ectopic postsynaptic-like membranes in skeletal muscle fibers. J. Neurosci. 19:1999;3376-3383.
34. Yang X., Arber S., William C., Li L., Tanabe Y., Jessell T.M., Birchmeier C., Burden S.J. Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron. 30:2001;399-410.
35. Lin W., Burgess R.W., Dominguez B., Pfaff S.L., Sanes J.R., Lee K.F. Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature. 410:2001;1057-1064.
36. Mori S., Ronnstrand L., Yokote K., Engstrom A., Courtneidge S.A., Claesson-Welsh L., Heldin C.H. Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases. EMBO J. 12:1993;2257-2264.
37. Baxter R.M., Secrist J.P., Vaillancourt R.R., Kazlauskas A. Full activation of the platelet-derived growth factor beta-receptor kinase involves multiple events. J. Biol. Chem. 273:1998;17050-17055.
38. Hirota S., Isozaki K., Moriyama Y., Hashimoto K., Nishida T., Ishiguro S., Kawano K., Hanada M., Kurata A., Takeda M.et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 279:1998;577-580.
39. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature. 411:2001;355-365.
40. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
41. Navaza J. AMoRe. an automated package for molecular replacement Acta Crystallogr. A50:1994;157-163.
42. Peitsch M.C. ProMod and Swiss-Model. Internet-based tools for automated comparative protein modelling Biochem. Soc. Trans. 24:1996;274-279.
43. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S.et al. Crystallography and NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921.
44. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119.
45. Casnellie J.E. Assay of protein kinases using peptides with basic residues for phosphocellulose binding. Methods Enzymol. 200:1991;115-120.
46. Ma Y., Lu Y., Zeng H., Ron D., Mo W., Neubert T.A. Characterization of phosphopeptides from protein digests using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and nanoelectrospray quadrupole time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 15:2001;1693-1700.